Acquiring Company
Edwards Lifesciences
Acquired Company
Vectorious Medical Technologies
Irvine
Tel AvivManufacturingBiotechnologyHealthcareHealth CareArtificial IntelligenceMedicalMedical DeviceBiotechnologyHealth CareMedicalDescription
Edwards Lifesciences has finalized its $497 million acquisition of Vectorious Medical Technologies. This transaction follows a previous investment where Edwards acquired a 52% stake. With this deal, Edwards now fully owns Vectorious, which specializes in heart failure treatment technology. The acquisition aims to enhance Edwards' offerings in the medical device sector.
Quick answer
Edwards Lifesciences is acquiring Vectorious Medical Technologies for $497 million, announced September 4, 2025. Edwards Lifesciences is based in Irvine, California, United States.
- How much did Edwards Lifesciences pay for Vectorious Medical Technologies?
- The reported deal value is $497 million.
- What does Edwards Lifesciences do?
- Edwards Lifesciences is the global leader of patient-focused innovations for structural heart disease and critical care monitoring.
- Where are Edwards Lifesciences and Vectorious Medical Technologies based?
- Edwards Lifesciences is based in Irvine, California, United States. Vectorious Medical Technologies is based in Tel Aviv, Tel Aviv District, Israel.
- Who are the decision-makers at Edwards Lifesciences?
- Fundz holds 4 contacts at Edwards Lifesciences. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Healthcare and Medical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Avanos Medical acquires Nexus Medical for growth (September 15, 2025)
- Gryphon Digital Technologies merges with American Bitcoin (August 29, 2025)
- OSR Holdings to acquire Woori IO for diabetes care (October 14, 2025)
- OSR Holdings to acquire Woori IO for healthcare innovation (July 24, 2025)
- AbbVie acquires Bretisilocin for mental health expansion (October 15, 2025)
- Bausch Health acquires DURECT for $63M, $63M (September 11, 2025)
Who to call at Edwards Lifesciences, and when
When Edwards Lifesciences changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Edwards Lifesciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Edwards Lifesciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Edwards Lifesciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Edwards Lifesciences makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Vectorious Medical Technologies?
Vectorious Medical Technologies was acquired by Edwards Lifesciences, based in Irvine. The deal was reported on September 4, 2025. Edwards Lifesciences is the global leader of patient-focused innovations for structural heart disease and critical care monitoring. Edwards Lifesciences is privately held and operates in Manufacturing.
When did Edwards Lifesciences acquire Vectorious Medical Technologies?
Edwards Lifesciences's acquisition of Vectorious Medical Technologies was reported on September 4, 2025. Edwards Lifesciences has finalized its $497 million acquisition of Vectorious Medical Technologies. This transaction follows a previous investment where Edwards acquired a 52% stake. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Vectorious Medical Technologies do?
Vectorious Medical Technologies develops novel treatment for heart failure patients which is based on physician directed, patients’ self-management paradigm. It is privately held, operating in Biotechnology, and is based in Tel Aviv.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.